Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel

about

Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel

Item

http://www.wikidata.org/entity/Q57821196

description

article

@en

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Identification of Quinoline-Ba ...... Index to the hERG Ion Channel

@en

Identification of Quinoline-Ba ...... Index to the hERG Ion Channel

@nl

type

Item

label

Identification of Quinoline-Ba ...... Index to the hERG Ion Channel

@en

Identification of Quinoline-Ba ...... Index to the hERG Ion Channel

@nl

prefLabel

Identification of Quinoline-Ba ...... Index to the hERG Ion Channel

@en

Identification of Quinoline-Ba ...... Index to the hERG Ion Channel

@nl

P1476

Identification of Quinoline-Ba ...... Index to the hERG Ion Channel

@en

P2093

Adam K Charnley

http://www.w3.org/2001/XMLSchema#string

Ami S Lakdawala

http://www.w3.org/2001/XMLSchema#string

Barbara Swift

http://www.w3.org/2001/XMLSchema#string

Barry S Brown

http://www.w3.org/2001/XMLSchema#string

Bartholomew J Votta

http://www.w3.org/2001/XMLSchema#string

Biva M Desai

http://www.w3.org/2001/XMLSchema#string

Brian T Donovan

http://www.w3.org/2001/XMLSchema#string

Carol A Capriotti

http://www.w3.org/2001/XMLSchema#string

Carol LePage

http://www.w3.org/2001/XMLSchema#string

David B Lipshutz

http://www.w3.org/2001/XMLSchema#string

P2860

Carbon-oxygen hydrogen bonding in biological structure and function

Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors

The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

A quantitative analysis of kinase inhibitor selectivity

A key role for the endothelium in NOD1 mediated vascular inflammation: comparison to TLR4 responses

Therapeutic targeting of NOD1 receptors

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.

Preclinical strategies to assess QT liability and torsadogenic potential of new drugs: the role of experimental models.

Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias.

P304

1039-1044

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.8B00344

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pamela A Haile

P577

2018-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30344914

http://www.w3.org/2001/XMLSchema#string

P932

6187414

http://www.w3.org/2001/XMLSchema#string